R
42.12
0.28 (0.67%)
Market Trend
Short Term | Medium Term | ||
Industry | Biotechnology (US) | Mixed | Bearish |
Biotechnology (Global) | Mixed | Bearish | |
Stock | Revolution Medicines, Inc. | Bullish | Bullish |
Stockmoo Score
0.3
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs. |
|
Sector | Healthcare |
Industry | Biotechnology |
Investment Style | Small Core |
52 Weeks Range | ||
Price Target Range | ||
High | 63.00 (Jefferies, 49.57%) | Buy |
Median | 55.50 (31.77%) | |
Low | 54.00 (JP Morgan, 28.21%) | Buy |
54.00 (Barclays, 28.21%) | Buy | |
Average | 57.13 (35.64%) | |
Total | 8 Buy | |
Avg. Price @ Call | 43.51 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
HC Wainwright & Co. | 12 Aug 2024 | 56.00 (32.95%) | Buy | 42.98 |
16 Jul 2024 | 56.00 (32.95%) | Buy | 46.77 | |
JP Morgan | 08 Aug 2024 | 54.00 (28.21%) | Buy | 41.98 |
Needham | 08 Aug 2024 | 61.00 (44.82%) | Buy | 41.98 |
16 Jul 2024 | 62.00 (47.20%) | Buy | 46.77 | |
Wedbush | 08 Aug 2024 | 59.00 (40.08%) | Buy | 41.98 |
Barclays | 18 Jul 2024 | 54.00 (28.21%) | Buy | 46.04 |
12 Jul 2024 | 52.00 (23.46%) | Buy | 45.14 | |
B of A Securities | 16 Jul 2024 | 55.00 (30.58%) | Buy | 46.77 |
Oppenheimer | 16 Jul 2024 | 55.00 (30.58%) | Buy | 46.77 |
Jefferies | 08 Jul 2024 | 63.00 (49.57%) | Buy | 39.58 |
Show more |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |